Outsourced Pharma White Papers

1. Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators 4/28/2025

   Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.

2. Mastering Technology Transfers: Our Blueprint For Success 4/16/2025

   Uncover how this expert approach to process transfer supports reliable, scalable commercial manufacturing in the rapidly growing biopharmaceutical market.

3. Driving Operational Excellence Using Machine Learning 12/13/2024

   Explore how advanced machine learning and data analytics are revolutionizing biopharmaceutical manufacturing and driving operational excellence.

4. Extractables And Leachables: Risk Management And Analytical Solutions 10/11/2023

   Partnering with a CDMO that offers comprehensive and robust E&L studies can help facilitate a smooth product launch by ensuring minimal impact from impurities, all while mitigating risks.

5. Overload Setting – Tricks And Techniques 9/23/2024

   Learn how a partner company that is committed to assisting manufacturers with calibration and optimal set-point establishment can serve as a valuable resource in achieving optimal tablet production.

6. Flexible Fill/Finish Solutions To Bridge The Clinical-To-Commercial Gap 7/23/2025

   As biopharma complexity grows, flexible CDMOs like Afton Scientific are essential for navigating evolving fill/finish needs, accelerated timelines, and regulatory uncertainty with agility and expertise.

7. Random & Semi-Targeted Integration In Cell Line Development 8/5/2025

   Compare random and semi-targeted integration strategies for stable cell line development, highlighting their impact on expression consistency, scalability, and regulatory considerations.

8. Preclinical Evaluation Of Vaccines And Antivirals In RSV Challenge SCID Mouse Models 6/10/2025

   Advance your RSV therapeutic pipeline with trusted, IND-enabling preclinical services that deliver clinically relevant data through optimized study designs and validated rodent models.

9. Immunogenicity Risk Assessment In Drug Candidate Selection 1/22/2025

   Identify and address potential anti-drug immune responses early in development to streamline your drug’s path to clinical success—start smart and finish fast.

10. Overcoming Challenges In AAV And LV Viral Vector Manufacturing 12/5/2023

    Manufacturing viral vectors leaves sponsors vulnerable to high costs, delays, and the possibility of failure. The right CDMO partner can help you reduce timelines and costs for viral vector production.